Regencell Bioscience Holdings Ltd Income Statement

Income Statement Jun2019 Jun2020 Jun2021 Jun2022 Jun2023 Jun2024 Jun2025
Revenue & cost
Revenue 0.03M0.02M0.21M0.37M
Cost of Revenue 0.00M0.11M0.00M0.03M0.26M0.13M0.01M
Operating items
Research & Development 0.23M0.39M0.44M2.51M1.58M1.07M0.95M
Selling, General & Administrative 0.16M0.31M0.94M5.08M4.43M3.55M2.81M
Restructuring Costs 3.25M2.76M2.54M
Other Operating Expenses 0.00M0.11M0.00M0.03M-2.98M-2.64M-2.53M
Operating Expenses 0.39M0.81M1.38M7.62M6.27M4.74M3.77M
Operating Income -0.39M-0.81M-1.38M-7.62M-6.27M-4.74M-3.77M
EBIT -0.39M-0.81M-1.38M-7.62M-6.27M-4.74M-3.77M
Non-operating items
Other Non Operating Income 0.21M0.37M0.19M
Non Operating Income 0.21M0.37M0.19M
Net income details
EBT -0.39M-0.81M-1.35M-7.59M-6.06M-4.36M-3.58M
Profit After Tax -0.39M-0.81M-1.35M-7.59M-6.06M-4.36M-3.58M
Income from Non-Controlling Interests -0.81M-1.35M0.15M-0.19M-0.06M
Income from Continuing Operations -0.39M-0.81M-1.35M-7.59M-6.06M-4.36M-3.58M
Consolidated Net Income -0.39M-0.81M-1.35M-7.59M-6.06M-4.36M-3.58M
Income towards Parent Company -0.39M-0.81M-1.35M-7.59M-6.06M-4.36M-3.58M
Net Income towards Common Stockholders -0.39M0.81M-1.35M-7.45M-5.96M-4.36M-3.58M
Additional items
EPS (Basic) 0.080.13-0.58-1.19-0.87-0.72
EPS (Weighted Average and Diluted) -0.58-1.19-0.87-0.72
Shares Outstanding (Weighted Average) 480.40M480.40M480.40M494.49M494.49M494.49M
EBITDA -0.39M-0.81M-1.35M-7.59M-6.15M-4.32M-3.60M